Clinical trial Recruiting at 1 site Interventional Ages 18 to 89

New treatment for dizziness in people with multiple sclerosis

Official title: Daily Versus Intermittent Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

Run by Emory University · NCT06495138 · Data updated 2026-11-12

This study tests a new treatment using a special technology to see if personalized eye exercises can help reduce dizziness for people with multiple sclerosis.

Quick facts

Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment138 (estimated)
SponsorEmory University
Academic / other
Drugs / interventionsImmunotherapy
Locations1 site (Atlanta, Georgia)
StatusRecruiting
StartedApril 21, 2025
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedOctober 23, 2026
Trial IDNCT06495138 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a confirmed diagnosis of primary progressive or relapsing-remitting MS who experience dizziness and have a history of falls.

Probably not a fit

Patients with clinically isolated syndrome, significant cognitive impairment, or certain ocular conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of a novel treatment aimed at alleviating dizziness in individuals with multiple sclerosis (MS). It compares daily personalized gaze stabilization training to intermittent gaze stability training to determine which is more effective. The intervention utilizes a technology called StableEyes, designed to enhance gaze stability through a gradual approach to vestibular exercises. By targeting the vestibulo-ocular reflex, the study aims to improve vision stability and reduce dizziness, ultimately enhancing the quality of life for participants.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce dizziness and improve daily functioning for patients with multiple sclerosis.

How similar studies have gone: Preliminary research has shown promising results for similar approaches, suggesting potential effectiveness for this novel treatment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Neurologist-confirmed diagnosis of primary progressive or relapsing and remitting MS per The 2017 Revision of the McDonald Criteria and the Magnetic Resonance Imaging in MS, or a healthy volunteer without a diagnosis of multiple sclerosis or any related neurological conditions
* Fluent in speaking and understanding English
* Subjects with multiple sclerosis have self-reported vestibular symptoms of dizziness, imbalance, and/or a history of at least two falls in the prior 12 months

Exclusion Criteria:

* Clinically isolated syndrome or radiologically isolated syndrome.
* Worsening MS symptoms during the prior 60 days
* Immunotherapy change in the prior 60 days
* Self-reported cognitive impairment that limits independence with basic and instrumental activities of daily living
* Systolic blood pressure \> 180 mmHg and/or diastolic blood pressure \> 90 mmHg at rest
* Static visual acuity with correction of worse than 1.0 logMAR
* Manifest ocular misalignment ≥ 5 diopters (e.g., tropia, lazy eye, strabismus}
* Convergence insufficiency
* Intra-nuclear ophthalmoplegia
* Vestibular Migraine
* Major orthopedic conditions that limit cervical spine range of motion or that alter walking
* Self-reported current or potential for pregnancy during enrollment
* Ongoing participation in vestibular rehabilitation for dizziness

Where it's running

  • Emory Univeristy
    Atlanta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.